Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| AIR | 8-K | bullish | 6/10 | AAR CORP. filed an 8-K furnishing an investor presentation detailing its agreement to acquire a 65% controlling interest | Oct 27, 2026 |
| ACLS | 8-K | neutral | 3/10 | Axcelis appointed Jeroen Delsman as EVP and CFO, effective November 12, 2026, succeeding interim CFO David Ryzhik who mo | Oct 27, 2026 |
| SXTP | 8-K | neutral | 5/10 | 60 Degrees Pharmaceuticals announced positive results from its expanded access study of tafenoquine combination regimens | Oct 27, 2026 |
| HUBB | 8-K | bullish | 6/10 | Hubbell reported Q3 2026 adjusted diluted EPS of $5.91, up 14% YoY, on net sales of $1.8725B (+25% YoY, organic +11%). T | Oct 27, 2026 |
| PCAR | 8-K | bullish | 6/10 | PACCAR reported Q3 2026 net income of $847.5M ($1.61 per diluted share) on revenues of $7.94B, compared to $590.0M ($1.1 | Oct 27, 2026 |
| CAC | 8-K | neutral | 4/10 | Camden National Corp reported Q3 2026 net income of $22.8M and diluted EPS of $1.34, up 8% and 7% YoY respectively. Net | Oct 27, 2026 |
| ECL | 8-K | neutral | 5/10 | Ecolab reported Q3 2026 adjusted diluted EPS of $2.18, in line with the consensus estimate of $2.17, and revenue of $4.6 | Oct 27, 2026 |
| ENTX | 8-K | neutral | 3/10 | Entera Bio appointed Dr. Juan Camilo Arjona Ferreira, Head of R&D and CMO at Organon, to its Board of Directors effectiv | Oct 27, 2026 |
| SFD | 8-K | bearish | 6/10 | Smithfield Foods reported Q3 fiscal 2026 sales of $3.4B (down 8.3% YoY) and GAAP diluted EPS of $0.23 (down from $0.63), | Oct 27, 2026 |
| CTS | 8-K | bullish | 6/10 | CTS reported Q3 2026 revenue of $149.6M (up 5% YoY) and adjusted diluted EPS of $0.77 (up $0.17 YoY), beating the consen | Oct 27, 2026 |
| CBC | 8-K | neutral | 5/10 | Central Bancompany reported Q3 2026 net income of $116.2 million ($0.48 per diluted share), up 19.7% YoY from $97.1 mill | Oct 27, 2026 |
| SLBK | 8-K | neutral | 4/10 | Skyline Bankshares reported Q3 2026 net income of $5.1 million ($0.90 per share), up from $4.1 million ($0.73 per share) | Oct 27, 2026 |
| IMSR | 8-K | neutral | 3/10 | Terrestrial Energy announced a $25 million share repurchase program authorized by its Board of Directors, representing a | Oct 27, 2026 |
| CVLT | 8-K | bullish | 6/10 | Commvault reported Q2 FY2027 subscription revenue of $269M (+21% YoY), SaaS revenue of $106M (+33% YoY), and subscriptio | Oct 27, 2026 |
| NWFL | 8-K | bullish | 6/10 | Norwood Financial Corp reported record Q3 2026 net income of $11.8M and record net interest income of $28.0M, both up sh | Oct 27, 2026 |
| ZURA | 8-K | neutral | 5/10 | Zura Bio reported a net loss of $25.8 million ($0.20 per share) for Q3 2026, compared to a net loss of $18.0 million ($0 | Oct 27, 2026 |
| WVE | 8-K | bullish | 6/10 | Wave Life Sciences reported Q3 2026 revenue of $13.2M (up 73% YoY from $7.6M) and a GAAP net loss of $61.9M ($-0.30 per | Oct 27, 2026 |
| FTH | 8-K | neutral | 2/10 | Faeth Therapeutics appointed Adam Schayowitz, Ph.D., as a Class III director, expanding the board from six to seven memb | Oct 27, 2026 |
| KNSA | 8-K | bullish | 6/10 | Kiniksa reported Q3 2026 ARCALYST net product revenue of $286.0M, up ~58% YoY, and raised full-year 2026 ARCALYST guidan | Oct 27, 2026 |
| WFRD | 8-K | neutral | 3/10 | Weatherford International plc announced that the High Court of Ireland approved its redomestication from Ireland to Dela | Oct 27, 2026 |
| BA | 8-K | bearish | 5/10 | Boeing reported Q3 2026 revenue of $24.2B, up 4% YoY but slightly below the $24.37B consensus, with a GAAP loss per shar | Oct 27, 2026 |
| WSO | 8-K | bearish | 5/10 | Watsco reported record Q3 2026 revenue of $2.22 billion (+7% YoY), but EPS fell 5% to $3.77, missing the $4.09 consensus | Oct 27, 2026 |
| CLS | 8-K | neutral | 3/10 | Celestica Inc. filed an 8-K with an Investor and Analyst Day presentation containing historical financial data for FY 20 | Oct 27, 2026 |
| HCA | 8-K | neutral | 5/10 | HCA Healthcare reported Q3 2026 revenue of $19.849B (+3.6% YoY) and GAAP EPS of $7.27 (+4.5% YoY), but net income attrib | Oct 27, 2026 |
| SPGI | 8-K | bullish | 6/10 | S&P Global reported Q3 2026 revenue of $3.678B (+7% YoY) and GAAP diluted EPS of $4.45 (+26% YoY), both above consensus. | Oct 27, 2026 |
| IQV | 8-K | bullish | 6/10 | IQVIA reported Q3 2026 revenue of $4,428M (up 8.0% YoY) and adjusted diluted EPS of $3.34 (up 11.3% YoY), exceeding cons | Oct 27, 2026 |
| GWRE | 8-K | bullish | 7/10 | Guidewire Software announced a definitive agreement to acquire Hyperexponential Ltd for $1.7 billion in cash (base purch | Oct 27, 2026 |
| GLXY | 8-K | bullish | 6/10 | Galaxy Digital reported Q3 2026 net income of $323 million (diluted EPS $0.66, adjusted EPS $0.83) versus a net loss of | Oct 27, 2026 |
| RGEN | 8-K | bullish | 6/10 | Repligen reported Q3 2026 revenue of $209.3M, up 11% YoY as reported and 12.5% organic, beating the $206.7M consensus. A | Oct 27, 2026 |
| SHW | 8-K | bearish | 5/10 | Sherwin-Williams reported Q3 2026 revenue of $6.86B (+7.9% YoY), slightly above the $6.78B consensus, but adjusted EPS o | Oct 27, 2026 |